GlassScriptPhysician profile
Caroline Zhu
NPI 1184373292
$5,348.66
in general payments reported to CMS, 2019-2025
13 companies · $1,681 in 2025
The $1,681 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $164 · 2024: $3,504 · 2025: $1,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,021 · Travel and Lodging: $256 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,021.04 |
| Travel and Lodging | $255.62 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,642.09 | 2024 | |
| Genzyme Corporation | $1,306.62 | 2024-2025 | |
| Amgen INC. | $377.84 | 2024-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $373.25 | 2024-2025 | Nemluvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $297.65 | 2024-2025 | Spevigo |
| Kyowa Kirin, INC. | $241.99 | 2023-2024 | Poteligeo |
| Janssen Biotech, INC. | $239.94 | 2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $224.14 | 2024 | Libtayo, Dupixent |
| Lilly USA, LLC | $196.25 | 2024-2025 | Ebglyss |
| Janssen Scientific Affairs, LLC | $155.72 | 2024 | Tremfya |
| Biofrontera INC. | $128.86 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $121.91 | 2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $42.40 | 2023 | Winlevi, Absorica Ld |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Zhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.